Learn how to facilitate sound and transparent regulatory decision-making
Master of Medicines Regulatory Affairs is a continuing education programme targeted at professionals in the pharmaceutical industry. Admission requires a minimum of two years of relevant work experience.
Experts within regulatory affairs are essential for companies facing an increasingly complex approval process for bringing new products to market. As a Master of Medicines Regulatory Affairs, you can help secure your company a safe, coherent and successful regulatory process.
The scientific approach of this master’s programme enables you to argue for clinical relevance and scientific legitimacy to ensure a strong, reliable and quality-based storyline.
Part-time study for full-time employees
The 60 ECTS credits master’s programme (equivalent to 1 year of full-time study) is designed to be completed within 2 to 6 years of part-time study. Full-time study is not an option, as many courses are only available every second year.
All courses are designed with a minimum of classroom attendance, in order to fit the busy schedule of regulatory affairs specialist. All courses are lectured in Copenhagen, Denmark.
Sign up for individual courses or enroll in the full programme
The Master’s programme consists of compulsory courses (34 ECTS), fixed elective courses (4 ECTS), elective courses (10 ECTS) and a master's project (12 ECTS).
Clinical Development and Documentation*
Drug Regulatory Science
Discovery and Development of Medicines
Global Pharmaceutical Policy - Rationales and Stakeholders
The EU Regulatory Environment - Procedures and Applications*
The US Regulatory Environment*
Transparency and Trustworthiness in Drug Development
Safety of Medicines - From Non-clinical Development to Pharmacovigilance
Labeling as a Driver for Regulatory Strategy
Fixed elective courses (choose 1)
Quality - Drug Substance and Drug Products*
Biopharmaceuticals - Quality Development and Documentation*
Elective courses (preapproved)
Market Access for Pharmaceutical Products
Quality by Design (QbD) in Pharmaceutical Development
Biopharmaceuticals Drug Development
Value-Based Health Care - the future for the health care sector?
*Offered in a collaboration with Atrium, a private course provider established by the Danish Association of the Pharmaceutical Industry.
Master of Medicines Regulatory Affairs is developed in collaboration with Atrium, which is a private course provider established by the Danish Association of the Pharmaceutical Industry. Atrium contributes with 5 practice-based courses.
The programme provides you with a mix of practice-based competencies, in-depth scientific knowledge, and effective negotiation skills.
A comprehensive understanding of the regulatory process enables you to take a more strategic and tactic approach. This way, you can ensure innovation progress, maintain product safety, and yet obtain a sound and speedy marketing authorization.
Enroll in the master’s programme and:
Achieve a thorough insight into the regulatory process at all stages during drug development;
Become competent in analyzing, predicting and advising on drug regulations and directives;
Learn to critically examine legislation in regulatory science;
Get an overview of the differences in regulatory demands globally;
Understand how to organize the regulatory work across the classic safety, clinical and quality disciplines to prevent delays in the innovation process.
Enrollment fee: DKK 10,000
Course fees: From DKK 10,000 to 28,000
Full programme: From DKK 240,000
The cost for the full programme vary according to your enrolment status, choice of elective course and citizenship (see below).
The tuition fee is differentiated, but still fixed – negotiation is not an option
The Danish Government pays a Ministry subsidy for EU/EEA students, whereas all other students must pay the full course price.
Full course price: all non-EU/EEA citizens (actual costs)
Reduced course price: all EU/EEA citizens (costs partly covered through a Ministry subsidy)
All courses are provided at a lower cost for students enrolled in Master of Medicines Regulatory Affairs than for single course students, typically DKK 2,000 per course.
The University of Copenhagen does not offer tuition remission or scholarships
The University of Copenhagen does not offer any grants or scholarships. Nor can we answer inquiries regarding funding.
Admission and application
Admission criteria for individual courses or the full programme
The same admission criteria apply, whether you wish to follow individual courses or the full programme.
Relevant bachelor’s degree or equivalent
At least two years of relevant work experience within regulatory affairs or equivalent
Meet the language requirements stated at the programme website
Fill out the application form via the Master’s programme website, www.mra.ku.dk, and remember the required documentation.
If applying for individual courses, please use the link on the individual course pages. Application deadline for typically 8 weeks prior to the first day of lecture.
The programme has rolling admission, so applications are evaluated as they come in.
Residence permits and visas
Students from non-EU/EEA countries must obtain a visa before entering Denmark. Visa requirements to enter the country vary, so you must consult the Danish embassy or consulate in your area.
Admission to a part-time study programme does not warrant a residence permit as a student. For further information, please contact the Danish Immigration Service.
TYPE: Continuing Professional Development
PLACE: University of Copenhagen, Denmark
DURATION: 2-6 years part-time study
PARTICIPANTS: Regulatory affairs specialist employed in industry, regulatory agencies or consulting
ADMISSION: Continually admission for individual courses and the full programme
FURTHER INFO: www.mra.ku.dk
Duration and price
Start date: Open enrolment
Duration: 2 – 6 years part-time
Price: From DKK 10,000 to DKK 28,000 per course. From DKK 250,000 to DKK 290,000 for the full programme.
Deadline: The programme has a rolling admission and application are processed as they come in.